Pharmacologic inhibition of ketohexokinase prevents fructose-induced metabolic dysfunction

Marriott, 2010, Intake of added sugars and selected nutrients in the United States, national health and nutrition examination survey (NHANES) 2003-2006, Critical Reviews in Food Science and Nutrition, 50, 228, 10.1080/10408391003626223 Schulze, 2004, Sugar-sweetened beverages, weight gain, and incidence of type 2 diabetes in young and middle-aged women, Journal of the American Medical Association, 292, 927, 10.1001/jama.292.8.927 Palmer, 2008, Sugar-sweetened beverages and incidence of type 2 diabetes mellitus in African American women, Archives of Internal Medicine, 168, 1487, 10.1001/archinte.168.14.1487 Yang, 2014, Added sugar intake and cardiovascular diseases mortality among US adults, JAMA Internal Medicine, 174, 516, 10.1001/jamainternmed.2013.13563 Dhingra, 2007, Soft drink consumption and risk of developing cardiometabolic risk factors and the metabolic syndrome in middle-aged adults in the community, Circulation, 116, 480, 10.1161/CIRCULATIONAHA.107.689935 Despland, 2017, A randomized-controlled clinical trial of high fructose diets from either Robinia honey or free fructose and glucose in healthy normal weight males, Clinical Nutrition ESPEN, 19, 16, 10.1016/j.clnesp.2017.01.009 Abdelmalek, 2012, Higher dietary fructose is associated with impaired hepatic adenosine triphosphate homeostasis in obese individuals with type 2 diabetes, Hepatology, 56, 952, 10.1002/hep.25741 Abid, 2009, Soft drink consumption is associated with fatty liver disease independent of metabolic syndrome, Journal of Hepatology, 51, 918, 10.1016/j.jhep.2009.05.033 Assy, 2008, Soft drink consumption linked with fatty liver in the absence of traditional risk factors, Canadian Journal of Gastroenterology, 22, 811, 10.1155/2008/810961 Ma, 2015, Sugar-sweetened beverage, diet soda, and fatty liver disease in the Framingham Heart Study cohorts, Journal of Hepatology, 63, 462, 10.1016/j.jhep.2015.03.032 Abdelmalek, 2010, Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease, Hepatology, 51, 1961, 10.1002/hep.23535 Mohan, 2015, WHO recommends reducing intake of 'free sugars' by adults and children, The National Medical Journal of India, 28, 165 Vos, 2014, Nutrition, nonalcoholic fatty liver disease and the microbiome: recent progress in the field, Current Opinion in Lipidology, 25, 61, 10.1097/MOL.0000000000000043 Cozma, 2014, The role of fructose, sucrose and high-fructose corn syrup in diabetes, European Endocrinology, 10, 51, 10.17925/EE.2014.10.01.51 Stanhope, 2009, Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans, Journal of Clinical Investigation, 119, 1322, 10.1172/JCI37385 Taskinen, 2017, Adverse effects of fructose on cardiometabolic risk factors and hepatic lipid metabolism in subjects with abdominal obesity, Journal of Internal Medicine, 282, 187, 10.1111/joim.12632 Swarbrick, 2008, Consumption of fructose-sweetened beverages for 10 weeks increases postprandial triacylglycerol and apolipoprotein-B concentrations in overweight and obese women, British Journal of Nutrition, 100, 947, 10.1017/S0007114508968252 Schwarz, 2017, Effects of dietary fructose restriction on liver fat, de novo lipogenesis, and insulin kinetics in children with obesity, Gastroenterology, 153, 743, 10.1053/j.gastro.2017.05.043 Stanhope, 2015, A dose-response study of consuming high-fructose corn syrup-sweetened beverages on lipid/lipoprotein risk factors for cardiovascular disease in young adults, American Journal of Clinical Nutrition, 101, 1144, 10.3945/ajcn.114.100461 Lustig, 2016, Isocaloric fructose restriction and metabolic improvement in children with obesity and metabolic syndrome, Obesity, 24, 453, 10.1002/oby.21371 Gugliucci, 2016, Short-term isocaloric fructose restriction lowers apoC-III levels and yields less atherogenic lipoprotein profiles in children with obesity and metabolic syndrome, Atherosclerosis, 253, 171, 10.1016/j.atherosclerosis.2016.06.048 Bonthron, 1994, Molecular basis of essential fructosuria: molecular cloning and mutational analysis of human ketohexokinase (fructokinase), Human Molecular Genetics, 3, 1627, 10.1093/hmg/3.9.1627 Diggle, 2009, Ketohexokinase: expression and localization of the principal fructose-metabolizing enzyme, Journal of Histochemistry and Cytochemistry, 57, 763, 10.1369/jhc.2009.953190 Sachs, 1942, Essential fructosuria: its pathophysiology, American Journal of Diseases of Children, 63, 252, 10.1001/archpedi.1942.02010020037004 Laron, 1961, Essential benign fructosuria, Archives of Disease in Childhood, 36, 273, 10.1136/adc.36.187.273 Ishimoto, 2012, Opposing effects of fructokinase C and A isoforms on fructose-induced metabolic syndrome in mice, Proceedings of the National Academy of Sciences of the U S A, 109, 4320, 10.1073/pnas.1119908109 Ishimoto, 2013, High-fat and high-sucrose (western) diet induces steatohepatitis that is dependent on fructokinase, Hepatology, 58, 1632, 10.1002/hep.26594 Softic, 2018, Divergent effects of glucose and fructose on hepatic lipogenesis and insulin signaling, Journal of Clinical Investigation, 128, 1199, 10.1172/JCI99009 Shepherd, 2021, Ketohexokinase inhibition improves NASH by reducing fructose-induced steatosis and fibrogenesis, JHEP Reports, 3, 100217, 10.1016/j.jhepr.2020.100217 Futatsugi, 2020, Discovery of PF-06835919: a potent inhibitor of ketohexokinase (KHK) for the treatment of metabolic disorders driven by the overconsumption of fructose, Journal of Medicinal Chemistry, 63, 13546, 10.1021/acs.jmedchem.0c00944 Meissen, 2016, Phenotyping hepatocellular metabolism using uniformly labeled carbon-13 molecular probes and LC-HRMS stable isotope tracing, Analytical Biochemistry, 508, 129, 10.1016/j.ab.2016.06.019 Shirai, 2016, The application of paraphenylenediamine staining for assessment of phospholipidosis, Toxicologic Pathology, 44, 1160, 10.1177/0192623316673921 Bligh, 1959, A rapid method of total lipid extraction and purification, Canadian Journal of Biochemistry and Physiology, 37, 911, 10.1139/o59-099 Morrison, 1964, Preparation of fatty acid methyl esters and dimethylacetals from lipids with boron fluoride--methanol, The Journal of Lipid Research, 5, 600, 10.1016/S0022-2275(20)40190-7 Lee, 1994, In vivo measurement of fatty acids and cholesterol synthesis using D2O and mass isotopomer analysis, American Journal of Physiology, 266, E699 Guo, 2000, De novo lipogenesis in adipose tissue of lean and obese women: application of deuterated water and isotope ratio mass spectrometry, International Journal of Obesity and Related Metabolic Disorders, 24, 932, 10.1038/sj.ijo.0801256 Elhamdy, 1993, Separation of non-polar lipids by high performance liquid chromatography on a cyanopropyl column, Journal of High Resolution Chromatography, 16, 55, 10.1002/jhrc.1240160112 Kaluzny, 1985, Rapid separation of lipid classes in high yield and purity using bonded phase columns, The Journal of Lipid Research, 26, 135, 10.1016/S0022-2275(20)34412-6 Allen, 2018, A mathematical analysis of adaptations to the metabolic fate of fructose in essential fructosuria subjects, American Journal of Physiology. Endocrinology and Metabolism, 315, E394, 10.1152/ajpendo.00317.2017 Jang, 2018, The small intestine converts dietary fructose into glucose and organic acids, Cell Metabolism, 27, 351, 10.1016/j.cmet.2017.12.016 Sun, 2012, Fructose metabolism in humans - what isotopic tracer studies tell us, Nutrition and Metabolism, 9, 89, 10.1186/1743-7075-9-89 Iizuka, 2004, Deficiency of carbohydrate response element-binding protein (ChREBP) reduces lipogenesis as well as glycolysis, Proceedings of the National Academy of Sciences of the U S A, 101, 7281, 10.1073/pnas.0401516101 Dentin, 2012, Glucose 6-phosphate, rather than xylulose 5-phosphate, is required for the activation of ChREBP in response to glucose in the liver, Journal of Hepatology, 56, 199, 10.1016/j.jhep.2011.07.019 Matschinsky, 2009, Assessing the potential of glucokinase activators in diabetes therapy, Nature Reviews Drug Discovery, 8, 399, 10.1038/nrd2850 Davies, 1990, Fructose 1-phosphate and the regulation of glucokinase activity in isolated hepatocytes, European Journal of Biochemistry, 192, 283, 10.1111/j.1432-1033.1990.tb19225.x Lanaspa, 2013, Endogenous fructose production and metabolism in the liver contributes to the development of metabolic syndrome, Nature Communications, 4, 2434, 10.1038/ncomms3434 Lanaspa, 2014, Endogenous fructose production and fructokinase activation mediate renal injury in diabetic nephropathy, Journal of the American Society of Nephrology, 25, 2526, 10.1681/ASN.2013080901 Bremer, 2011, Fructose-fed rhesus monkeys: a nonhuman primate model of insulin resistance, metabolic syndrome, and type 2 diabetes, Clinical Translational Science, 243, 10.1111/j.1752-8062.2011.00298.x Butler, 2020, Role of angiopoietin-like protein 3 in sugar-induced dyslipidemia in rhesus macaques: suppression by fish oil or RNAi, The Journal of Lipid Research, 61, 376, 10.1194/jlr.RA119000423 Rezvani, 2013, Effects of sugar-sweetened beverages on plasma acylation stimulating protein, leptin and adiponectin: relationships with metabolic outcomes, Obesity, 21, 2471, 10.1002/oby.20437 Schwarz, 2015, Effect of a high-fructose weight-maintaining diet on lipogenesis and liver fat, The Journal of Cinical Endocrinology and Metabolism, 100, 2434, 10.1210/jc.2014-3678 Hieronimus, 2020, Dietary fructose and dyslipidemia: new mechanisms involving apolipoprotein CIII, Current Opinion in Lipidology, 31, 20, 10.1097/MOL.0000000000000653 Abdul-Wahed, 2017, Sweet sixteenth for ChREBP: established roles and future goals, Cell Metabolism, 26, 324, 10.1016/j.cmet.2017.07.004 Erion, 2013, The role of the carbohydrate response element-binding protein in male fructose-fed rats, Endocrinology, 154, 36, 10.1210/en.2012-1725 Herman, 2016, The sweet path to metabolic demise: fructose and lipid synthesis, Trends in Endocrinology and Metabolism, 27, 719, 10.1016/j.tem.2016.06.005 Kim, 2017, Intestinal, but not hepatic, ChREBP is required for fructose tolerance, JCI Insight, 2, 10.1172/jci.insight.96703 Kim, 2016, ChREBP regulates fructose-induced glucose production independently of insulin signaling, Journal of Clinical Investigation, 126, 4372, 10.1172/JCI81993 Jang, 2020, The small intestine shields the liver from fructose-induced steatosis, Nature Metabolism, 2, 586, 10.1038/s42255-020-0222-9 Andres-Hernando, 2020, Deletion of fructokinase in the liver or in the intestine reveals differential effects on sugar-induced metabolic dysfunction, Cell Metabolism, 32, 117, 10.1016/j.cmet.2020.05.012 Tesz, 2020, Finding the sweet spot: parsing tissue-specific contributions of fructose metabolism, Cell Metabolism, 32, 6, 10.1016/j.cmet.2020.06.009 Todoric, 2020, Fructose stimulated de novo lipogenesis is promoted by inflammation, Nature Metabolism, 2, 1034, 10.1038/s42255-020-0261-2